?Flow Cytometry Shared Resource The Flow Cytometry Shared Resource (FCSR) has been a Cancer Center-supported Shared Resource since 1991. The mission of the FCSR is to deliver high-throughput, multi-dimensional analysis and cell sorting using state-of-the-art equipment for Mays Cancer Center (MCC) members, University of Texas Health San Antonio (UT Health SA) investigators, and others in the San Antonio area. The FCSR occupies over 800 sq. ft. of laboratory space and is conveniently accessible by MCC members. FCSR services include multiparameter analysis and sorting of subpopulations of cells; cell cycle analysis; single cell cloning and sorting for downstream genomics/transcriptomics; measurements of reactive nitrogen and oxygen species (NOS and ROS), pH, Ca++ fluxes and fluxes of different vital dyes; study of mitochondrial damage; and determination of activated caspases. The FCSR also offers consultative services including experimental design, instrument training, and assistance with grant and manuscript writing (including preparation of figures, methods sections, and budgets). The FCSR provides MCC members access to two flow cytometry cell sorters, four conventional analyzers, a spectral analyzer and, most recently, a mass cytometer. The FCSR is led by Scientific Director Michael Berton, Ph.D., Associate Professor of Microbiology, Immunology & Molecular Genetics. Ms. Karla Gorena is a Technical Director and daily operations manager of the FCSR. Nameer Kirma, Ph.D., Associate Professor of Molecular Medicine, joined the FCSR as a second Technical Director in 2018 to supervise the Helios mass cytometer. The FCSR is administratively supported by the UT Health SA Office of the Vice President for Research (VPR) and the MCC. During 2018, 35 MCC members with peer-reviewed funding used the FCSR. In addition, the FCSR contributed to 53 cancer-related publications during the last reporting period (2014-2018).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-25
Application #
10025088
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-08-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Chalela, P; Munoz, E; Inupakutika, D et al. (2018) Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 12:109-115
Chalela, Patricia; Muñoz, Edgar; Gallion, Kipling J et al. (2018) Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study. Transl Behav Med 8:439-449
Weiner, Marc; Gelfond, Jon; Johnson-Pais, Teresa L et al. (2018) Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother 62:
Liu, Jinyou; Sareddy, Gangadhara R; Zhou, Mei et al. (2018) Differential Effects of Estrogen Receptor ? Isoforms on Glioblastoma Progression. Cancer Res 78:3176-3189
Chakravarthy, Divya; Muñoz, Amanda R; Su, Angel et al. (2018) Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett 419:103-115
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Cooney, Jeffrey D; Lin, An-Ping; Jiang, Daifeng et al. (2018) Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3K? in Mature B-cell Malignancies. Clin Cancer Res 24:1103-1113
Zhu, Haiyan; Gu, Xiang; Xia, Lu et al. (2018) A Novel TGF? Trap Blocks Chemotherapeutics-Induced TGF?1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clin Cancer Res 24:2780-2793
Bandyopadhyay, Abhik; Favours, Edward; Phelps, Doris A et al. (2018) Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatr Blood Cancer 65:
Azpurua, Jorge; Mahoney, Rebekah E; Eaton, Benjamin A (2018) Transcriptomics of aged Drosophila motor neurons reveals a matrix metalloproteinase that impairs motor function. Aging Cell 17:

Showing the most recent 10 out of 989 publications